Abstract: A power-control device comprises an energy-import portion and an energy-export portion. The power-control device may additionally include a general processing and power supply circuit providing linear control of the power-control device's production of power to the load. The energy-import portion is coupled between a VLINE terminal and a load terminal, and is capable of importing energy to the load terminal during a first portion and a third portion of an alternating voltage VAC waveform. The energy-export portion is coupled between the load terminal and a NEU terminal, and is capable of exporting energy from the load terminal during a second portion and a fourth portion of the alternating voltage VAC waveform. The first, second, third and fourth portions of the alternating voltage VAC waveform are equal to a period of the alternating voltage VAC waveform and respectively are consecutive during the period of the alternating voltage VAC waveform.

Abstract: A power-control device comprises an energy-import portion and an energy-export portion. The power-control device may additionally include a general processing and power supply circuit providing linear control of the power-control device's production of power to the load. The energy-import portion is coupled between a VLINE terminal and a load terminal, and is capable of importing energy to the load terminal during a first portion and a third portion of an alternating voltage VAC waveform. The energy-export portion is coupled between the load terminal and a NEU terminal, and is capable of exporting energy from the load terminal during a second portion and a fourth portion of the alternating voltage VAC waveform. The first, second, third and fourth portions of the alternating voltage VAC waveform are equal to a period of the alternating voltage VAC waveform and respectively are consecutive during the period of the alternating voltage VAC waveform.

Abstract: A curable formulation containing a metal aprotic organosilanoxide compound of formula (I): {R1—Si(R2)(R3)—[O—Si(R4)(R5)]m—O}n-M1(?L)o(X1)p (I), wherein M1 is a metal atom Al, Ce, Fe, Sn, Ti, V, or Zr, a polymerizable organosilicon compound, an organosilicon crosslinker for crosslinking the polymerizable organosilicon compound, and a silicon-based adhesion promoter. Also included is a cured product of curing the curable formulation; a manufactured article containing or prepared from the curable formulation or cured product; and methods of making and using the foregoing. The cured product may be free-standing or disposed on a substrate.

Abstract: A curable formulation containing a metal aprotic organosilanoxide compound of formula (I): {R1—Si(R2)(R3)—[O—Si(R4)(R5)]m—O}n-M1(?L)o(X1)p (I), wherein M1 is a metal atom Al, Ce, Fe, Sn, Ti, V, or Zr, a polymerizable organosilicon compound, an organosilicon crosslinker for crosslinking the polymerizable organosilicon compound, and a silicon-based adhesion promoter. Also included is a cured product of curing the curable formulation; a manufactured article containing or prepared from the curable formulation or cured product; and methods of making and using the foregoing. The cured product may be free-standing or disposed on a substrate.

Abstract: Disclosed are mammalian expression vectors for expressing simultaneous expression of immunoglobulins as both a secreted and cell surface bound form.

Abstract: Disclosed are mammalian expression vectors for expressing simultaneous expression of immunoglobulins as both a secreted and cell surface bound form.

Abstract: Disclosed are mammalian expression vectors for expressing simultaneous expression of immunoglobulins as both a secreted and cell surface bound form.

Abstract: Disclosed are mammalian expression vectors for expressing simultaneous expression of immunoglobulins as both a secreted and cell surface bound form.